We are proud to announce that our Drug Interaction Visualizer has been selected as a finalist for the SCOPE Best of Show Awards. Based on real-world data from the FDA, our visualizer enables clinical research professionals to explore drug interactions and identify potential risks.
The eyesON Drug-Drug Interaction visualizer provides unique profiles of the most common adverse events and side effects of the market's most frequently prescribed and used FDA-regulated drugs.
At Cyntegrity, we're on a mission to deliver the highest possible data quality in clinical trials. That's why we're thrilled to have been recognized by Microsoft as a valuable use case. Don't miss out on reading how we're making a difference in the biopharma industry by checking out our customer story on Microsoft's website.
The Butterfly Challenge is a program developed by Cyntegrity that invites companies to come together and make a positive impact on the world. The program encourages collaboration and teamwork among businesses in order to create a brighter future for all.
It was a year of exciting collaborations, major accomplishments, and new beginnings at Cyntegrity. From partnering with MongoDB on The Butterfly Challenge to successfully completing SOC 2 examination and engaging over 1,200 clinical researchers through our popular mindsON workshops, we made the most of 2022. Don't miss our full recap of all that we achieved!
IDC MarketScape has listed Cyntegrity as one of the top 8 RBQM vendors in its "Worldwide Life Science R&D Risk-Based Monitoring Solutions 2022 Vendor Assessment" study.
Is Oncology Clinical Trials your domain? Then get your free coupon for the RBQM Essentials White Belt eCourse no later than 1 November and save $190.
The so-called "cucumber regulation" may mean nothing to you. However, it guarantees comparable products to retailers, consumers, and processors across Europe, a standard. Standardization drives quality over time and develops global trust. Do we have standards in clinical research? Yes, but not enough, and they may not always be adhered to.
With the release of the final ICH E8(R1) version this month, sponsors and CROs are encouraged to embrace a Quality by Design culture. This final paper is part of a more general Good Clinical Practice (GCP) “Renovation” that involves the modernization of ICH E8 and subsequent renovation of ICH E6.
MyRBQM Portal V6.8.2 released! We're constantly working to improve your Risk-Based Quality Management experience. Download the summary of what has changed.
